Forum Pulls Pharmacy Chain MedPlus Over Home Sample No-Show, Slaps Rs 25,000 Fine

Published On 2025-12-07 18:05 GMT | Update On 2025-12-07 18:05 GMT

Hospital Fined

Chennai: The Chennai North District Consumer Disputes Redressal Commission has pulled up Medplus Diagnostics and Healthcare Services for failing to carry out a scheduled home sample collection, directing the company to pay Rs 25,000 in compensation to a city-based couple.

The complainants, R Raja and his wife Nirmala of Arumbakkam, had booked a home blood sample collection through the Medplus website in May 2025. After paying Rs 899, they received confirmation that a technician would visit their residence. Nirmala, who is diabetic and hypertensive, was advised by Medplus staff to observe strict overnight fasting and temporarily stop her prescribed medicines prior to the test, as per a recent media report by DT NEXT.

However, on the day of the appointment, no technician turned up. Calls to customer care as well as the Anna Nagar branch went unanswered. Adding to their frustration, the couple received conflicting calls from Medplus asking when they would come to the diagnostic centre—despite having explicitly booked a home-service slot.

Also Read: MedPlus to open 350 stores in Delhi-NCR at 100 crore investment

Because she followed the instructions to fast and withhold medication, Nirmala suffered discomfort, dizziness, and fluctuating blood sugar levels, causing both physical strain and emotional distress. Their work commitments were also disrupted. Although the test fee was eventually refunded—but only after multiple follow-ups and a legal notice—the couple maintained that the refund did not compensate for the risk and hardship they experienced.

After examining the complaint, the Commission comprising President D. Gopinath and members Kavitha Kannan and T.R. Sivakumar concluded that the company’s failure to provide the confirmed service, coupled with medically unsafe instructions, amounted to deficiency in service, unfair trade practice, and medical negligence, DT NEXT reported.

In view of the above, the panel ordered Medplus to pay Rs 20,000 as compensation for the suffering and inconvenience caused, along with Rs 5,000 as litigation costs. Further, it added, the amount must be paid within two months of receiving the order.

Also Read: Kerala HC upholds medical council rule requiring clinical clerkship for FMGs taught online during COVID

Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Susmita Roy

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Forum Pulls Pharmacy Chain MedPlus Over Home Sample No-Show, Slaps Rs 25,000 Fine

Similar News

Delhi HC Bars Shilpa Medicare From Making, Selling Ruxolitinib Drugs in Patent Row

Dr Reddy's Denosumab Biosimilar AVT03 Faces USFDA Setback After Plant Inspection

After 40 Years, USFDA Approves Vanda Pharma's Motion Sickness Drug Nereus

Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans Appeal

Sun Pharma Gets CDSCO Panel Nod to Market Semaglutide Injection in Weight Loss Indication

Sonbhadra police announce reward of Rs 25,000 each on 4 in codeine syrup trafficking case

Jubilant Generics invests Rs 20 lakh in Jubilant Pharma Canada

Wockhardt WCK 5222 granted accelerated assessment by EMA